England - London • Industry focus
Latham & Watkins
Led by Robbie McLaren, the team at Latham & Watkins is noted for its ‘great sector knowledge’ and strength in handling the full spectrum of corporate matters, including IPOs, licensing transactions, and financing issues. McLaren primarily handles cross-border M&A, in addition to venture and growth capital investments. Senior associate Oliver Mobasser primarily focuses on assisting biotech, medtech, and pharmaceutical companies with strategic transactions and divestments.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘Great sector knowledge. Very responsive. Creative thinking and well resourced teams.’
Key clients
- Abcam
- Acino Pharma
- Amgen
- Astellas Pharma
- Atai
- Baxter
- BenevolentAI
- BC Partners
- Collplant
- CVC Capital Partners
- Eleusis
- Exscientia
- GlaxoSmithKline
- KKR
- Ligand Pharmaceuticals
- Meira GTx
- Mereo BioPharma
- Nordic Capital
- Norgine
- Novo Holdings
- Oasmia
- Osler Diagnostics
- Permira
- Pharmanovia
- Pharmaseeds
- Pharmathen
- ProPharma Group
- Silverlake Partners
- Sobi
- Soundbite
- Synthon
- Theramex
- Zogenix
Practice head
The lawyer(s) leading their teams.
Robbie McLaren